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Monday, March 7, 2011 277aand has a much shorter M3-M4 loop. To determine whether (or not) these
segments are crucial for the function of a eukaryotic acetylcholine-glutamate
Cys-loop chimeric receptor (a7-GluClbR), we deleted those segments of the
chimera that are missing in GLIC. Ligand-binding assays performed on trans-
fected living cells indicate that chimeras lacking most of the M3-M4 loop can
readily bind 3H-a-bungarotoxin (a competitive antagonist) and nicotine (an
agonist). These deletion chimeras were visualized on the cell surface by con-
focal microscopy using rhodaminylated a-bungarotoxin and specific anti-
bodies. In addition, chimeras lacking the M3-M4 loop display ACh-
induced currents with unchanged EC50, Hill coefficient and ionic selectivity.
In contrast, chimeras lacking the N-terminal helical segment do not bind 3H-
a-bungarotoxin. However, these N-terminus-truncated receptors migrate as
non-degraded proteins in SDS PAGE and are readily visualized on the sur-
face of transfected cells with specific anti-HA tag antibodies. Electrophysio-
logical experiments are currently performed to determine whether (or not)
acetylcholine, nicotine or protons activate the N-terminus truncated chimeras.
Supported by the Wolfson Family Foundation and the Israel Science Founda-
tion.
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Number of Extracellular-Transmembrane Interfaces Required for Activa-
tion of Homomeric Cys-Loop Receptors
Natalia Andersen, Jeremias Corradi, Mariana Bartos, Steven M. Sine,
Cecilia B. Bouzat.
Each subunit in a homo-pentameric Cys-loop receptor contains a specialized
transduction zone located at the extracellular-transmembrane interface that
links the ligand binding domain to the ion conductive channel. To determine
the contribution of each transduction zone to stability of the open channel,
we constructed a subunit with both a disabled transduction zone and a reporter
mutation that alters unitary conductance, and co-expressed mutant and normal
subunits. The resulting receptors show single channel current amplitudes that
are quantized according to the number of reporter mutations per receptor, al-
lowing correlation of mean open time with the number of intact transduction
zones. We find that each transduction zone contributes an equal increment to
the stability of the open channel. However by combining subunits with either
disabled agonist binding sites or transduction zones, we find that although
each binding site is formed by a pair of subunits, detectable channel opening
requires an intact transduction zone in both subunits. By manipulating the num-
bers and locations of transduction zones and binding sites, we find that a trans-
duction zone in a subunit at an inactive binding site can still stabilize the open
channel. The findings show that although the agonist binding sites and trans-
duction zones contribute allosterically to open channel stability, their stoichi-
ometry and positioning requirements are distinct.
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Identification of the Binding Site for the Anthelmintic Drug Ivermectin in
Cys-Loop Receptors
Tali Gortler, Ruthi Tobi, Marina Weissman, Ilya Pittel, Nurit Degani-Katzav,
Yoav Paas.
Ivermectin (IVM) is an antiparasitic drug widely used in veterinary medicine,
mainly in cattle, to kill intestinal worms. Additionally, it is used to treat human
parasitic diseases like Onchocerciasis (river blindness). The major target of
IVM is a heteropentameric glutamate-gated chloride channel (GluCla/b recep-
tor), which is unique to invertebrates and belongs to the Cys-loop receptor su-
perfamily. Nanomolar concentrations of IVM irreversibly activate the native
GluCla/bR, thereby causing sustained hyperpolarization, suppression of ner-
vous impulses, paralysis and death of the nematode. Little is known about
the IVM binding site(s). We first studied a chimeric a7-GluClb receptor that
consists of the ligand-binding domain (LigBD) of the a7 nicotinic acetylcho-
line receptor (a7-nAChR) and the channel domain of a homopentameric
GluClbR. IVM was expected to increase the chimera’s activity since the activ-
ity of the a7-nAChR is enhanced by IVM and the homopentameric GluClbR is
irresponsive to IVM. Surprisingly, IVM strongly inhibited the chimeric a7-
GluClbR suggesting that IVM does not bind exclusively to either of the do-
mains, but binds somewhere at the interface between the LigBD and the pore
domain. Next, we explored the natural target of IVM, the GluCla/bR. Since
the a-subunit is known to be responsible for IVM binding by the native Glu-
Cla/bR, we replaced the b8b9 and Cys loops of the b-subunit by the homolo-
gous loops of the a-subunit. These two loops reach the interface between the
LigBD and the pore domain. Our results show that the aforementioned loop
swapping significantly enhances receptor activation by IVM. Furthermore,
site-specific mutagenesis suggests that IVM binds at the interface between
the LigBD and the pore domain, in a crevice between the b8b9 loop and the
Cys loop of two adjacent subunits. Supported by the Wolfson Foundation
and the Israel Science Foundation.1510-Pos Board B420
Transmembrane Domain Packing in Cys-Loop Receptors: What Can we
Learn from Prokaryotes?
Grace Brannigan, Jerome Henin, Roderic Eckenhoff, Michael Klein.
The significance of large gaps in protein density observed in the cryo-EM
structure (2BG9) of the nicotinic acetylcholine receptor (nAChR) transmem-
brane domain remains a pressing question. Although it was originally pro-
posed that the gaps were filled with water, water-filled pockets are not
stable under simulation, causing collapse of the transmembrane domain. Al-
ternative explanations include the possibility that the gaps are filled with cho-
lesterol or other lipid, as proposed by our group, or that the gaps are an
artifact of the experimental method. Recent crystal structures of prokaryotic
homologues, including GLIC, do not include such gaps, supporting the latter
scenario. However, here we show through homology modeling that models of
the nAChR based on GLIC still retain low protein density in the extracellular
half of the TM domain, due to consistently smaller residue volume in that
region of the nAChR compared to GLIC. Simulations of this model over
the 100ns time scale also display collapse that increases amino acid density
in this region of the protein, although for this model collapse largely pro-
ceeds by significant widening of the pore rather than reduction in the overall
footprint. An analysis of residue volume, determined from sequence, is pre-
sented across identified prokaryotic, eukaryotic anionic, and eukaryotic cat-
ionic members of the pentameric ligand-gated ion channels family,
demonstrating that residue volume has been consistently lost as channels be-
come less primitive, and that a tightly-packed nAChR would require a sub-
stantially tighter packing of backbone helices than what is observed in
prokaryotic channels.
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Oligomeric Structure of Muscarinic and Adrenergic Receptors in Live
Cells
Luca F. Pisterzi, Michael R. Stoneman, Fei Huang, Julie A. Oliver, James
W. Wells, Valerica Raicu.
We have determined the oligomeric size and configuration of fluorophore-
tagged M1, M2, b1, and b2 receptors in the plasma membrane of Chinese
hamster ovary (CHO) cells by examining the distribution of FRET efficien-
cies measured at the level of single pixels. The receptors were fused at the N-
terminus to enhanced green or yellow fluorescent protein, and complemen-
tary pairs were co-expressed at different ratios of donor to acceptor (i.e.,
eGFP2-M1 and eYFP-M1, eGFP
2-M2 and eYFP-M2, eGFP
2-b1 and eYFP-
b1, or eGFP
2-b2 and eYFP-b2). Pixel-level emission spectra were recorded
from images captured in a single plane; the relative contribution of each flu-
orophore then was determined by spectral deconvolution and used to calcu-
late the corresponding apparent FRET efficiency. The distributions of
efficiencies from 20 cells were analyzed in concert as a sum of Gaussians,
with the number of components (n) and the relationships among the means
taken as predicted for a dimer (n = 1), a triangular trimer (n = 2), and a tet-
ramer configured as a square (n = 3) and a rhombus (n = 5). Distributions
from each of the four receptors required 5 Gaussians, the means of which
were related in the manner predicted for a rhombus. The inverse agonists at-
ropine and timolol were without effect on the number of components or the
relationship among the means detected for the M2 muscarinic receptor and
the b2 adrenergic receptor, respectively. Homo-oligomers of the M1, M2,
b1, and b2 receptors therefore appear to be rhombic tetramers in CHO cells.
The configuration is unaffected by inverse agonists, at least in the case of the
M2 and b2 receptors.
Mechanosensitive Channels
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Mscl Channels as Nanovales for the Controlled Release of Liposome-En-
capsulated Compounds
Alexander F.-W. Foo, Michael J. Landsberg, Andrew R. Battle, Brad
J. Marsh, Ben Hankamer, Boris Martinac.
MscL acts as an osmotically-activated nanovalve, allowing bacteria to respond
to hypo-osmotic stress by opening nanometer-size channel pores. The underly-
ing mechanism of channel activation by membrane tension has been obtained
for MscL channels reconstituted into artificial liposomes using patch clamp,
EPR and FRET spectroscopy in combination with computational modeling
of channel dynamics during channel opening. Given the large size of the
MscL pore (>25 A˚), we have investigated its suitability for use as a nanovalve
enabling controlled release of liposome-encapsulated compounds. Liposomes
present one of the major forms of particulate drug carriers and provide an ex-
cellent method of encapsulation of highly toxic drugs, for example. In this
study we describe methods for generating small liposomes of uniform size
